BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35430567)

  • 21. Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression.
    Yu C; Xiong C; Tang J; Hou X; Liu N; Bayliss G; Zhuang S
    Theranostics; 2021; 11(6):2706-2721. PubMed ID: 33456568
    [No Abstract]   [Full Text] [Related]  

  • 22. JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing β-MHC expression.
    Guo Z; Lu J; Li J; Wang P; Li Z; Zhong Y; Guo K; Wang J; Ye J; Liu P
    Mol Cell Endocrinol; 2018 Dec; 477():1-14. PubMed ID: 29753027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons.
    Messer HG; Jacobs D; Dhummakupt A; Bloom DC
    J Virol; 2015 Mar; 89(6):3417-20. PubMed ID: 25552720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
    Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X
    J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
    Romero OA; Vilarrubi A; Alburquerque-Bejar JJ; Gomez A; Andrades A; Trastulli D; Pros E; Setien F; Verdura S; Farré L; Martín-Tejera JF; Llabata P; Oaknin A; Saigi M; Piulats JM; Matias-Guiu X; Medina PP; Vidal A; Villanueva A; Sanchez-Cespedes M
    Nat Commun; 2021 Jul; 12(1):4319. PubMed ID: 34262032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination Treatment of a Phytochemical and a Histone Demethylase Inhibitor-A Novel Approach towards Targeting TGFβ-Induced EMT, Invasion, and Migration in Prostate Cancer.
    Dalpatraj N; Naik A; Thakur N
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival.
    Xu Z; Xia Y; Xiao Z; Jia Y; Li L; Jin Y; Zhao Q; Wan L; Yi T; Yu Y; Wen Q; Zhu Y; Qin B; Zhang F; Shen J
    Sci Rep; 2019 Jan; 9(1):868. PubMed ID: 30696880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
    Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor.
    Das A; Arifuzzaman S; Yoon T; Kim SH; Chai JC; Lee YS; Jung KH; Chai YG
    Sci Rep; 2017 Jul; 7(1):6554. PubMed ID: 28747667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells.
    Sui A; Xu Y; Li Y; Hu Q; Wang Z; Zhang H; Yang J; Guo X; Zhao W
    Oncotarget; 2017 Sep; 8(40):68591-68598. PubMed ID: 28978140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Chen D; Cai B; Zhu Y; Ma Y; Yu X; Xiong J; Shen J; Tie W; Zhang Y; Guo F
    Clin Epigenetics; 2024 Apr; 16(1):51. PubMed ID: 38576048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.
    Kochat V; Equbal Z; Baligar P; Kumar V; Srivastava M; Mukhopadhyay A
    PLoS One; 2017; 12(3):e0173977. PubMed ID: 28328977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JMJD3 downregulates IL4i1 aggravating lipopolysaccharide-induced acute lung injury via H3K27 and H3K4 demethylation.
    Gao Y; Wang N; Jia D
    Environ Toxicol; 2023 Mar; 38(4):754-769. PubMed ID: 36537648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma.
    Katagi H; Louis N; Unruh D; Sasaki T; He X; Zhang A; Ma Q; Piunti A; Shimazu Y; Lamano JB; Carcaboso AM; Tian X; Seluanov A; Gorbunova V; Laurie KL; Kondo A; Wadhwani NR; Lulla R; Goldman S; Venneti S; Becher OJ; Zou L; Shilatifard A; Hashizume R
    Clin Cancer Res; 2019 Sep; 25(18):5572-5583. PubMed ID: 31227500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmitate-TLR4 signaling regulates the histone demethylase, JMJD3, in macrophages and impairs diabetic wound healing.
    Davis FM; denDekker A; Joshi AD; Wolf SJ; Audu C; Melvin WJ; Mangum K; Riordan MO; Kunkel SL; Gallagher KA
    Eur J Immunol; 2020 Dec; 50(12):1929-1940. PubMed ID: 32662520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
    Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
    Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YAP represses intestinal inflammation through epigenetic silencing of JMJD3.
    Zhu H; Lu J; Fu M; Chen P; Yu Y; Chen M; Zhao Q; Wu M; Ye M
    Clin Epigenetics; 2024 Jan; 16(1):14. PubMed ID: 38245781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role and prospect of JMJD3 in stem cells and cancer.
    Yin X; Yang S; Zhang M; Yue Y
    Biomed Pharmacother; 2019 Oct; 118():109384. PubMed ID: 31545292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.